A nurse is assessing a newborn whose mother has a history of substance abuse during pregnancy. Which assessment finding would be most indicative of neonatal abstinence syndrome (NAS)?

High-pitched cry and hyperactive reflexes are classic signs of CNS hyperexcitability in NAS due to opioid withdrawal. Other options represent findings not typically associated with NAS, such as bradycardia (opioid intoxication) or macrosomia (maternal diabetes).

Understanding Neonatal Abstinence Syndrome (NAS)

Neonatal Abstinence Syndrome (NAS) is a clinical condition that results from the abrupt discontinuation of chronic in-utero substance exposure at the time of birth. While historically linked to opioid exposure, the syndrome's presentation can be influenced by a variety of psychoactive substances, including selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines, which can alter or exacerbate the clinical picture ^[3]. The pathophysiology centers on the sudden loss of a steady supply of a central nervous system (CNS) depressant or modulator, leading to a state of severe autonomic and CNS dysregulation in the newborn. This withdrawal manifests across multiple systems, primarily the neurologic, gastrointestinal, and autonomic nervous systems .

Analysis of the Correct Answer: High-Pitched Cry and Hyperactive Reflexes

The correct answer is High-pitched cry and hyperactive reflexes. This option captures the hallmark neurologic irritability that is central to the diagnosis of NAS. The newborn's CNS, having adapted to the depressant effects of substances like opioids in utero, enters a hyper-excitable state upon withdrawal. This is not a simple agitation but a profound disorganization of the nervous system. A high-pitched, shrill cry is a classic sign of this neurologic irritability, often described as distinctive and difficult to console. Hyperactive reflexes, including an exaggerated Moro reflex, tremors, and myoclonic jerks, are direct clinical manifestations of this CNS hyper-excitability ^[3]. These signs are key components of standardized assessment tools used to diagnose and manage NAS, such as the Finnegan Neonatal Abstinence Scoring System, which quantifies the severity of withdrawal based on these very findings .

Why the Other Options Are Incorrect

- Bradycardia and decreased muscle tone: This presentation suggests CNS depression, which is the opposite of the hyperactive state seen in withdrawal. While a newborn with recent in-utero exposure might present with these signs due to the direct pharmacologic effect of an opioid, the withdrawal syndrome itself is characterized by autonomic signs of stress, such as tachycardia and hypertonicity, not bradycardia and hypotonia ^[3].
- Macrosomia and hypoglycemia: This cluster of findings is more classically associated with maternal diabetes during pregnancy (gestational diabetes or pre-existing diabetes). Infants exposed to opioids in utero are more frequently associated with intrauterine growth restriction and low birth weight, not macrosomia . Hypoglycemia is not a primary feature of NAS, though poor feeding and excessive sucking can lead to metabolic instability.
- Cyanosis and respiratory depression: While transient tachypnea and respiratory distress can be seen in NAS due to autonomic instability, significant cyanosis and respiratory depression are more indicative of acute opioid intoxication or toxicity in the newborn period, not the withdrawal state. Withdrawal activates the sympathetic nervous system, leading to signs like tachypnea, not respiratory depression ^[3].

Clinical Application and Nursing Implications

The assessment of a newborn with suspected NAS requires a systematic, evidence-based approach. The variability in how NAS is diagnosed and managed across institutions is a recognized challenge, underscoring the importance of using validated scoring tools . The nurse's role is critical in the nonpharmacologic management of these infants, which is the first-line treatment. This involves creating a therapeutic environment that minimizes environmental stimuli to prevent escalating the infant's hyper-excitable state—dimming lights, reducing noise, and providing gentle, clustered care. The effectiveness of such care-model-based interventions in reducing the need for pharmacologic treatment and shortening hospital stays is a major focus of current research . Recognizing that the clinical presentation can be complicated by maternal polysubstance use and other factors like SSRIs is essential for accurate assessment and anticipating the severity of the withdrawal ^[3]. The constellation of a high-pitched cry, hyperactive reflexes, tremors, sleep disturbances, and gastrointestinal symptoms like poor feeding and vomiting forms the core clinical picture that guides both nursing care and the decision to escalate to pharmacologic therapy with agents like morphine or methadone .